Evidence map›Paper›PMID 34704622›Full record

ArticleBiometrics2023

Functional additive models for optimizing individualized treatment rules.

Hyung Park, Eva Petkova, Thaddeus Tarpey, R Todd Ogden

Abstract read
In one paragraph

Article in Biometrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hyung ParkDivision of Biostatistics, Department of Population Health, New York University, New York, USA.ORCID 0000-0002-8994-9583
Eva PetkovaDivision of Biostatistics, Department of Population Health, New York University, New York, USA.
Thaddeus TarpeyDivision of Biostatistics, Department of Population Health, New York University, New York, USA.
R Todd OgdenDepartment of Biostatistics, Columbia University, New York, USA.

Funding

Characterizing Placebo ResponseR01MH099003 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PETKOVA, EVA, TARPEY, THADDEUS · 2013 to 2021
$4.5M
NIMH NIH HHS R01 MH099003
6 · The paper itself

Abstract

A novel functional additive model is proposed, which is uniquely modified and constrained to model nonlinear interactions between a treatment indicator and a potentially large number of functional and/or scalar pretreatment covariates. The primary motivation for this approach is to optimize individualized treatment rules based on data from a randomized clinical trial. We generalize functional additive regression models by incorporating treatment-specific components into additive effect components. A structural constraint is imposed on the treatment-specific components in order to provide a class of additive models with main effects and interaction effects that are orthogonal to each other. If primary interest is in the interaction between treatment and the covariates, as is generally the case when optimizing individualized treatment rules, we can thereby circumvent the need to estimate the main effects of the covariates, obviating the need to specify their form and thus avoiding the issue of model misspecification. The methods are illustrated with data from a depression clinical trial with electroencephalogram functional data as patients' pretreatment covariates.

Indexed as

Models, StatisticalPrecision MedicineRandomized Controlled Trials as TopicHumansfunctional additive regressionindividualized treatment rulessparse additive modelstreatment effect-modifiers

Identifiers

PMID34704622
PMCPMC9043034

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.